Zibetti Dal Molin G[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2018	1
2019	1
2020	2
2023	0

Page 1

The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers.

Chelariu-Raicu A, Zibetti Dal Molin G, Coleman RL. Chelariu-Raicu A, et al. Among authors: zibetti dal molin g. Int J Gynecol Cancer. 2020 Oct;30(10):1608-1618. doi: 10.1136/ijgc-2020-001789. Epub 2020 Sep 14. Int J Gynecol Cancer. 2020. PMID: 32928926 Review.

Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors.

Zibetti Dal Molin G, Westin SN, Msaouel P, Gomes LM, Dickens A, Coleman RL. Zibetti Dal Molin G, et al. Int J Gynecol Cancer. 2020 Jan;30(1):89-93. doi: 10.1136/ijgc-2019-000714. Epub 2019 Dec 1. Int J Gynecol Cancer. 2020. PMID: 31792084

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma.

Zibetti Dal Molin G, Abrahão CM, Coleman RL, Maluf FC. Zibetti Dal Molin G, et al. Gynecol Oncol Res Pract. 2018 Aug 18;5:6. doi: 10.1186/s40661-018-0063-3. eCollection 2018. Gynecol Oncol Res Pract. 2018. PMID: 30147940 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year